Raquel Nunes, MD | Authors

University Hospital Southampton

Department of Urology

Tremona Road


SO43 7AX


Pertuzumab: Increasing the Options

March 15, 2014

At this point, there is expectation that pertuzumab given in the neoadjuvant setting will improve long-term efficacy. We welcome the opportunity to include pertuzumab in the neoadjuvant regimen of patients with HER2-positive breast cancer.